Table 2

Osteocyte viability (mean (SD))

Patients receiving GCs (nā€Š=ā€Š9)Hip fracture controls (nā€Š=ā€Š8)
Significantly different from control group: *p<0.05.
Viable620 (93)*743 (135)
Non-viable34 (45)15 (11)
Empty lacunae52 (49)36 (33)
Cells (n)706 (107)795 (150)
Viable (%)88 (8)*94 (4)
Non-viable (%)5 (6)2 (2)
Empty lacunae (%)7 (5)4 (4)
Non-viable+empty lacunae (%)128*6 (4)